Company · positioning
IlluminaIncumbent
Positioned in 3 collision spaces.
3Collision spaces
Nanotechnology×Genetics
55.5Index
Population-scale sequencing that defines the genetic targets nanomedicine must address.
Open collisionGene×Data science
45.7Index
Sequencing-data scale leader increasingly investing in ML-based variant interpretation and secondary analysis.
Open collisionGene×Microfluidics
40.9Index
Sequencing giant whose flow-cell chemistry and single-cell partnerships pull it toward microfluidic sample prep.
Open collision